Join us for the next edition of the 2022-23 CanVECTOR National Thrombosis Seminars series titled "LMWH and Cancer Mortality: Basic Science for Pathophysiology with Insights from the PERIOP-01 Trial."
Featuring: Dr. Marc Carrier & Dr. Rebecca Auer
1. To understand the mechanisms linking hypercoagulability and metastatic disease following cancer surgery;
2. To briefly discuss potential antimetastatic properties of low molecular weight heparin (LMWH);
3. To review the results of the PERIOP-01 trial assessing the role of extended duration thromboprophylaxis with LMWH in patients undergoing localized colorectal cancer resection
The event will feature a 15 minute Q&A following the presentation.